Sium Ahmed, Abdullah Mohammad Shohael, Tanvir Ahamed, Razu Ahmed, Shawon Ahmed, H M Shahid Hassan
{"title":"Understanding public perspectives on genetically engineered Brinjal and the adoption of modern biotechnology in Bangladesh.","authors":"Sium Ahmed, Abdullah Mohammad Shohael, Tanvir Ahamed, Razu Ahmed, Shawon Ahmed, H M Shahid Hassan","doi":"10.3389/fbioe.2024.1471201","DOIUrl":null,"url":null,"abstract":"<p><p>The agricultural sector in Bangladesh is currently facing numerous challenges. The country is currently endeavoring to adopt modern biotechnological tools, such as genetic engineering, to modify crops with the aim of ensuring food security. Notably, Bt Brinjal represents a significant milestone as the first genetically engineered (GE) food crop commercially cultivated in South Asia. Public perception and awareness are crucial steps forward for accepting and commercializing GE crops within society. The study discussed here aims to assess public perception and awareness regarding modern biotechnology and GE crops, focusing mainly on Bt Brinjal in Bangladesh. A random survey considered demographic factors such as age, gender, hometown, educational qualification, and occupation to explore the public attitudes towards Bt Brinjal and modern biotechnology. Approximately one-third of those surveyed considered Bt Brinjal safe for consumption, and a third expressed a willingness to buy Bt Brinjal, while nearly two-thirds believed it would gain popularity in the market alongside other crops. Most respondents recognized the necessity of utilizing modern biotechnology for crop improvement beyond Bt Brinjal, and respondents with science backgrounds displayed higher awareness and a more positive attitude than those with limited education or non-science backgrounds. This study explores the public perceptions of Bt Brinjal and the adoption of modern biotechnology in Bangladesh by examining factors such as knowledge dissemination, acceptance levels, and concerns related to GE crops, and offers a meaningful perspective that can shape decision-making processes to promote agricultural sustainability and achieve relevant sustainable development goals in Bangladesh.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371734/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1471201","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The agricultural sector in Bangladesh is currently facing numerous challenges. The country is currently endeavoring to adopt modern biotechnological tools, such as genetic engineering, to modify crops with the aim of ensuring food security. Notably, Bt Brinjal represents a significant milestone as the first genetically engineered (GE) food crop commercially cultivated in South Asia. Public perception and awareness are crucial steps forward for accepting and commercializing GE crops within society. The study discussed here aims to assess public perception and awareness regarding modern biotechnology and GE crops, focusing mainly on Bt Brinjal in Bangladesh. A random survey considered demographic factors such as age, gender, hometown, educational qualification, and occupation to explore the public attitudes towards Bt Brinjal and modern biotechnology. Approximately one-third of those surveyed considered Bt Brinjal safe for consumption, and a third expressed a willingness to buy Bt Brinjal, while nearly two-thirds believed it would gain popularity in the market alongside other crops. Most respondents recognized the necessity of utilizing modern biotechnology for crop improvement beyond Bt Brinjal, and respondents with science backgrounds displayed higher awareness and a more positive attitude than those with limited education or non-science backgrounds. This study explores the public perceptions of Bt Brinjal and the adoption of modern biotechnology in Bangladesh by examining factors such as knowledge dissemination, acceptance levels, and concerns related to GE crops, and offers a meaningful perspective that can shape decision-making processes to promote agricultural sustainability and achieve relevant sustainable development goals in Bangladesh.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.